Reuters logo
BRIEF-DongKook Pharmaceutical to divest contrast medium business into new subsidiary
March 21, 2017 / 6:33 AM / 6 months ago

BRIEF-DongKook Pharmaceutical to divest contrast medium business into new subsidiary

March 21 (Reuters) - DongKook Pharmaceutical Co Ltd :

* Says it will divest contrast medium business into new subsidiary named Dongkook Life Science Co., Ltd

* Expected divestiture effective date is May 1

Source text in Korean: goo.gl/jSsahh

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below